The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.
The current medications composing HCV combination therapy are being challenged by Valeant Pharmaceuticals. A recent study reported that HCV therapy with interferon and Viramidine® has fewer side effects than today's standard combination therapy.
Continue reading »Scientists have discovered a protein necessary for liver cell regeneration, an ability that is directly impacted by liver disease. The identification of this protein in helping the liver to heal itself opens up a new realm of liver disease treatment possibilities.
Continue reading »An unlikely ally has been uncovered for Hepatitis C treatment. Interferon and ribavirin treatment is known to inflict severe side effects resulting in low retention rates. While the link is not yet concrete, medical marijuana appears to reduce those side effects, improving a person's chance of completing treatment.
Continue reading »Magnetic Resonance Imaging (MRI) technology can now help detect end stage liver disease. Needle biopsies will quickly become archaic as this painless, low-risk and accurate method continues to demonstrate promise in evaluating liver fibrosis.
Continue reading »Results of a Phase II study indicate that the oral medication Suvus (TM) can significantly lower HCV viral load without any major side effects. Because it was only tested to battle HCV genotype 4a, this medication may not directly benefit those with other HCV genotypes. However, hope lies in the fact that progress is being made against the virus as a whole, with new breakthroughs occurring every day.
Continue reading »Researchers have uncovered a gene capable of preventing HCV replication. With modern technology's ability to use genetic microbiology in the fight against disease, this discovery could lead to viable treatment developments for Hepatitis C.
Continue reading »A novel approach to hepatitis C treatment will be presented at this year's annual meeting of the American Association of Liver Diseases. The preliminary results for a new class of drug designed to destroy both HCV viral particles and HCV infected cells show great promise. Bavituximab's recognition at this high-profile and well-respected event signifies this drug's potential.
Continue reading »Two companies committed to finding a vaccine for hepatitis C have released encouraging news on their progress. Tripep and Inovio's efforts to introduce a genetically engineered medicine through a patented DNA delivery system appear to stimulate immunity against Hepatitis C. As it evolves, this technology represents great hope for controlling the spread of the Hepatitis C virus.
Continue reading »One-third of all HIV positive patients are also infected with the hepatitis C virus. A new diagnostic test allows physicians to quickly identify both viruses with a single blood sample. With this diagnostic tool, doctors can immediately begin tailoring a comprehensive treatment plan.
Continue reading »While not well known, the condition known as a bleeding esophogeal varice poses a very real threat to those suffering from a compromised liver. Learn what makes this condition so dangerous and learn how best to stop the bleeding and restore normal blood circulation.
Continue reading »Inside you'll discover:
You'll also receive the latest news and information to support liver health.
Rest assured, we will not rent your email to anyone.
You should receive your email with links to the reports shortly. If you do not, please check your spam/junk folder.
If you still haven't received our email after a few minutes, please feel free to contact us.
Close Window
